|
|
||||||||
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112
Endomorphin 1 and 2, newly discovered
endogenous ligands for the µ-opioid receptor, have vasodepressor
activity in the rat. In the present study, the mechanism mediating
hemodynamic responses to endomorphin 2 and the endomorphin analog
[D-Ala2]endomorphin 2 (TAPP) was investigated in the
rat. Intravenous injections of TAPP and endomorphin 2 produced similar
dose-dependent decreases in systemic arterial pressure and were
~10-fold more potent than Met-enkephalin. TAPP and endomorphin 2 decreased heart rate, cardiac output, and total peripheral resistance.
Under constant-flow conditions, injections of TAPP and endomorphin 2 into the perfusion circuit produced decreases in hindquarter perfusion
pressure, and vasodilator responses were attenuated by the opioid
receptor antagonist naloxone. Hindquarter vasodilator responses to TAPP and endomorphin 2 were attenuated by the nitric oxide synthase inhibitor N
-nitro-L-arginine methyl
ester (L-NAME; 50 mg/kg iv), whereas responses to the
endothelium-independent vasodilators calcitonin gene-related peptide,
diethylamine/nitric oxide, and isoproterenol were not changed.
Hindquarter vasodilator responses to TAPP and endomorphin 2 were not
altered by the cyclooxygenase inhibitor sodium meclofenamate, the
ATP-dependent K+ channel antagonist U-37883A, or the
presence of a time-delay coil in the perfusion circuit. These results
indicate that vasodilator responses to TAPP and endomorphin 2 are
mediated by the activation of a naloxone-sensitive opioid receptor and
the release of nitric oxide from the endothelium within the hindquarter
vascular bed of the rat.
opioid receptor agonists; naloxone-sensitive mechanism; nitric oxide release; regional vascular bed
This article has been cited by other articles:
![]() |
K.-i. Hayashida, T. Takeuchi, T. Ozaki, H. Shimizu, K. Ando, A. Miyamoto, and E. Harada Bovine lactoferrin has a nitric oxide-dependent hypotensive effect in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R359 - R365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iemitsu, T. Miyauchi, S. Maeda, S. Sakai, T. Kobayashi, N. Fujii, H. Miyazaki, M. Matsuda, and I. Yamaguchi Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R2029 - R2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Champion, D. J. Villnave, A. Tower, P. J. Kadowitz, and A. L. Hyman A novel right-heart catheterization technique for in vivo measurement of vascular responses in lungs of intact mice Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H8 - H15. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Champion, T. J. Bivalacqua, F. M. D'Souza, L. A. Ortiz, J. R. Jeter, K. Toyoda, D. D. Heistad, A. L. Hyman, and P. J. Kadowitz Gene Transfer of Endothelial Nitric Oxide Synthase to the Lung of the Mouse In Vivo : Effect on Agonist-Induced and Flow-Mediated Vascular Responses Circ. Res., June 25, 1999; 84(12): 1422 - 1432. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |